ArticleNeurology(R) neuroimmunology & neuroinflammation2018

Dimethyl fumarate as a first- vs second-line therapy in MS: Focus on B cells.

Elsebeth Staun-Ram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.